Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

ClinicalTrials.gov ID: NCT01670032

Public ClinicalTrials.gov record NCT01670032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double Blind, Randomized, Vehicle Controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of CD 07223 1.5% Topical Gel in Impetigo

Study identification

NCT ID
NCT01670032
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
NovaBay Pharmaceuticals, Inc.
Industry
Enrollment
328 participants

Conditions and interventions

Conditions

Interventions

  • Experimental: CD07223 1.5 % Topical Gel BID Drug
  • Experimental: CD07223 1.5% Topical Gel TID Drug
  • Placebo Comparator: CD07223 vehicle gel BID Drug
  • Placebo Comparator: CD07223 vehicle gel TID Drug

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2012
Primary completion
Jul 31, 2013
Completion
Jul 31, 2013
Last update posted
Aug 11, 2014

2012 – 2013

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
SRCR, Inc Bell Gardens California 90201
Skin Care research Inc Boca Raton Florida 33486
Eastern Research, Inc Hialeah Florida 33013
Cyn3rgy Research Gresham Oregon 97030
Cheraw Pediatrics, P.A. Cheraw South Carolina 29520
Integrity Clinical Research, Inc Milan Tennessee 38358
Sealy Urgent Care Center Sealy Texas 77474

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01670032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2014 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01670032 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →